Is RAS blockade routinely indicated in hypertensive kidney transplant patients?
- 4 October 2007
- journal article
- review article
- Published by Springer Nature in Current Hypertension Reports
- Vol. 9 (5) , 422-429
Abstract
There is a high incidence of hypertension after kidney transplantation, which has been associated with the development of left ventricular hypertrophy, an increased risk for acute rejection, lower graft survival, and increased mortality. The pathogenesis of post-transplant hypertension is multifactorial, and therefore optimum therapy for it is not clearly defined. Historically, use of renin-angiotensin system (RAS) blockade in post-transplant hypertension has been limited given concerns of inducing worsening allograft function. Recent data demonstrated that subjects with post-transplant hypertension can be treated effectively with RAS blockers, and that these agents may offer significant additional benefits beyond blood pressure control. Review of the literature suggests that RAS blockers should be considered as useful agents for treatment of post-transplant hypertension not due to transplant renal artery stenosis.Keywords
This publication has 55 references indexed in Scilit:
- Exploring type I angiotensin (AT1) receptor functions through gene targetingActa Physiologica Scandinavica, 2004
- Effect of Angiotensin II Receptor Blocker on Plasma Levels of TGF-β1 and Interstitial Fibrosis in Hypertensive Kidney Transplant PatientsAmerican Journal of Nephrology, 2003
- Does transforming growth factor b1 play a role in the pathogenesis of chronic allograft rejection?Transplant International, 1999
- Renal allograft survival following acute rejection correlates with blood pressure levels and histopathologyKidney International, 1999
- ACE Inhibitor Versus β-Blocker for the Treatment of Hypertension in Renal Allograft RecipientsHypertension, 1999
- Interactions of Transforming Growth Factor-β and Angiotensin II in Renal FibrosisHypertension, 1998
- ANTIHYPERTENSIVE DRUG TREATMENT IN CHRONIC RENAL ALLOGRAFT REJECTION IN THE RATTransplantation, 1996
- Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensivesKidney International, 1990
- Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjectsKidney International, 1989
- Inhibition of Angiotensin-Converting Enzyme in Renal-Transplant Recipients with HypertensionNew England Journal of Medicine, 1983